AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT(the “Agreement”) is entered into this 26th day of May, 2008 (the “Effective Date”), between JAMES W. YOUNG, PH.D (“Executive”) and SUNESIS PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
SUNESIS PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT UNDER THE 2006 EMPLOYMENT COMMENCEMENT INCENTIVE PLANStock Option Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Sunesis Pharmaceuticals, Inc. (the “Company”), pursuant to its 2006 Employment Commencement Incentive Plan (the “Plan”) hereby grants to the Optionee listed below (“Optionee”), an option to purchase the number of shares of the Company’s Stock set forth below. This option is subject to all of the terms and conditions as set forth herein and in the Stock Option Agreement and the Plan, each of which are attached hereto and incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Stock Option Agreement.
RELEASE AGREEMENTRelease Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations
Acceptance of Option AmendmentAcceptance of Option Amendment • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations
By signing below, I hereby accept the offer of Sunesis Pharmaceuticals, Inc. (the “Company”) to amend my outstanding stock options (set forth on Schedule 1 hereto) that will have vested as of my termination of employment with the Company, together with any options that will vest in the event I sign that certain Release Agreement provided to me by the Company on June 13, 2008 and I allow such Release Agreement to become effective (collectively, “Options”) to extend the post-termination exercise period of such Options until the earlier of (i) the original end of the term of each such Option or (ii) June 30, 2009. I understand that any Option so amended may cease to qualify as an “incentive stock option” to the extent such Option previously would have qualified as an “incentive stock option.” I have been encouraged by the Company to consult with my tax advisor for guidance on the tax implications of this Acceptance of Option Amendment. Except as described in this Acceptance of Option Amen
RELEASE AGREEMENTRelease Agreement • August 7th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations
